Arcturus Therapeutics Holdings ARCT
NASDAQ ARCT
$13.70 -0.76 (-5.26%)
At close: Sep 29, 2026 · 4:00 PM EDT

Arcturus Therapeutics Holdings (ARCT) EV to EBITDA (2022 - 2023)

Updated

Arcturus Therapeutics Holdings' EV to EBITDA came in at 5.78 for Q3 2023, down 39.0% from the prior quarter.

Analysis

Arcturus Therapeutics Holdings (ARCT) EV to EBITDA (2022 - 2023) Analysis & Trends

Over the trailing twelve months to Sep 30, 2023, Arcturus Therapeutics Holdings reported EV to EBITDA of -10.48; for FY2022, it was 4.27.

  • The five-year range for quarterly EV to EBITDA is 3.89 (Q1 2023) to 9.48 (Q2 2023).
  • Business Quant data shows ARCT's EV to EBITDA at 9.48 (Q2 2023), 3.89 (Q1 2023) and 4.26 (Q4 2022) in the three quarters before Q3 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Arcturus Therapeutics Holdings 411.00 Mn -403.13 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 5.78
Jun 30, 2023 9.48
Mar 31, 2023 3.89
Dec 31, 2022 4.26
API Access

Arcturus Therapeutics Holdings EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=ARCT&period=max&api_key=YOUR_API_KEY